Heteologous saRNA-Prime, DNA Dual-Antigen-Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies
A. Rice, M. Verma, E. Voigt, P. Battisti, S. Beaver, S. Reed, K. Dinkins, S. Mody, L. Zakin, S. Tanaka, B. Morimoto, W. Higashide, C. A. Olson, E. R. Gabitzsch, J. T. Safrit, , P. Soon-Shiong
This study evaluates heterologous vaccination with two SARS-CoV-2 vaccines in mice, finding enhanced humoral and T-cell responses and broad neutralizing activity against variants.
bioRxiv · Nov 29, 2021 · PreprintImmunology